CSAG2 polyclonal antibody
* The price is valid only in USA. Please select country.
-
More Files
- More Functions
Western Blot (Cell lysate)
Western blot analysis of CSAG2 expression in Jurkat cell lysate (10 ug/lane) with CSAG2 polyclonal antibody (0.5 ug/mL).
-
Specification
Product Description
Rabbit polyclonal antibody raised against synthetic peptide of CSAG2.
Immunogen
A synthetic peptide corresponding to human CSAG2.
Host
Rabbit
Reactivity
Human
Form
Liquid
Quality Control Testing
Antibody Reactive Against Synthetic Peptide.
Recommend Usage
The optimal working dilution should be determined by the end user.
Storage Buffer
In PBS (0.08% sodium azide)
Storage Instruction
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.Note
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Applications
Western Blot (Cell lysate)
Western blot analysis of CSAG2 expression in Jurkat cell lysate (10 ug/lane) with CSAG2 polyclonal antibody (0.5 ug/mL).Enzyme-linked Immunoabsorbent Assay
-
Gene Info — CSAG2
-
Publication Reference
-
Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers.
Janjic B, Andrade P, Wang XF, Fourcade J, Almunia C, Kudela P, Brufsky A, Jacobs S, Friedland D, Stoller R, Gillet D, Herberman RB, Kirkwood JM, Maillere B, Zarour HM.
Journal of Immunology 2006 Aug; 177(4):2717.
Application：ELISA, Human, Seum from patients with Breast cancer, Lung cancer, Melanoma.
-
Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene.
Ohta M, Tanaka F, Sadanaga N, Yamaguchi H, Inoue H, Mori M.
Oncology Reports 2006 Jun; 15(6):1529.
-
Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Aung PP, Oue N, Mitani Y, Nakayama H, Yoshida K, Noguchi T, Bosserhoff AK, Yasui W.
Oncogene 2006 Apr; 25(17):2546.
-
Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers.
- +1-909-264-1399
+1-909-992-0619
Toll Free : +1-877-853-6098 - +1-909-992-3401
- sales@abnova.com